Pharma Mar, S.A. (BME:PHM)
Spain · Delayed Price · Currency is EUR 75.50
-0.65 (-0.85%)
Feb 6, 2026, 4:19 PM CET
Pharma Mar Market Cap
Pharma Mar has a market cap or net worth of €1.31 billion as of February 6, 2026. Its market cap has decreased by -11.68% in one year.
Market Cap
1.31B
Enterprise Value
1.21B
Revenue
179.28M
Ranking
n/a
PE Ratio
39.04
Stock Price
€75.50
Market Cap Chart
Since November 2, 2015, Pharma Mar's market cap has decreased from 1.80B to 1.31B, a decrease of -27.16%. That is a compound annual growth rate of -3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 1.33B | 3.00% |
| Dec 31, 2025 | 1.29B | -7.20% |
| Dec 31, 2024 | 1.39B | 88.09% |
| Dec 29, 2023 | 738.49M | -36.23% |
| Dec 30, 2022 | 1.16B | 12.13% |
| Dec 30, 2021 | 1.03B | -21.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.75B |
| Laboratorios Farmaceuticos Rovi | 3.73B |
| Almirall | 2.78B |
| Faes Farma | 1.63B |
| Clínica Baviera | 842.24M |
| Oryzon Genomics | 250.36M |
| Laboratorio Reig Jofre | 224.64M |
| Atrys Health | 222.31M |